Clinical trial
Neuromodulation and Language Acquisition (Project Stage Ia)
NCT00102284 · University Hospital Muenster, Other · Terminated
Key facts
| NCT number | NCT00102284 |
|---|---|
| Title | Neuromodulation and Language Acquisition (Project Stage Ia) |
| Official title | Improved Language Acquisition Through Neuromodulation, Project Stage Ia |
| Lead sponsor | University Hospital Muenster, Other |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | levodopa, rivastigmine, pergolid, modafinil |
| Enrollment | 100 |
| Start date | Mar 1, 2004 |
| Completion | Apr 1, 2005 |
| First posted | Jan 27, 2005 |
| Last update posted | Jan 27, 2010 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: